National Health Investors (NYSE: NHI) reported Q2 Normalized FFO of $1.22, $0.01 better than the analyst estimate of $1.21. Revenue for the quarter came in at $61.2 million versus the consensus estimate of $58.08 million.

GUIDANCE:

National Health Investors sees FY2016 Normalized FFO of $4.84 - $4.88, versus the consensus of $4.87.

For earnings history and earnings-related data on National Health Investors (NHI) click here.